Bausch Health Companies Inc (BHC) concluded trading on Wednesday at a closing price of $6.18, with 4.64 million shares of worth about $28.69 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.87% during that period and on June 18, 2025 the price saw a gain of about 7.85%. Currently the company’s common shares owned by public are about 369.54M shares, out of which, 291.10M shares are available for trading.
Stock saw a price change of 15.95% in past 5 days and over the past one month there was a price change of 33.19%. Year-to-date (YTD), BHC shares are showing a performance of -23.33% which decreased to -2.22% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.96 but also hit the highest price of $9.85 during that period. The average intraday trading volume for Bausch Health Companies Inc shares is 2.40 million. The stock is currently trading 24.35% above its 20-day simple moving average (SMA20), while that difference is up 25.82% for SMA50 and it goes to -10.56% lower than SMA200.
Bausch Health Companies Inc (NYSE: BHC) currently have 369.54M outstanding shares and institutions hold larger chunk of about 57.51% of that.
The stock has a current market capitalization of $2.28B and its 3Y-monthly beta is at 0.28. It has posted earnings per share of -$0.11 in the same period. It has Quick Ratio of 0.97. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BHC, volatility over the week remained 5.84% while standing at 3.29% over the month.
Analysts are in expectations that Bausch Health Companies Inc (BHC) stock would likely to be making an EPS of 0.93 in the current quarter, while forecast for next quarter EPS is 1.15 and it is 4.38 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.82 which is 1.1 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 0.98 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -0.74% while it is estimated to increase by 10.00% in next year. EPS is likely to shrink at an annualized rate of 6.74% for next 5-years, compared to annual growth of 52.33% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on August 02, 2024 offering an Underweight rating for the stock and assigned a target price range of between $9 and $3 to it. Coverage by Raymond James stated Bausch Health Companies Inc (BHC) stock as a Mkt perform in their note to investors on July 10, 2024, suggesting a price target of $8 for the stock. Stock get a Hold rating from Truist on July 29, 2022.
